DBV Technologies S.A., a pioneering biopharmaceutical company headquartered in France, focuses on developing innovative treatments for food allergies and other immune-mediated diseases. Founded in 2002, the company has made significant strides in the field of immunotherapy, particularly with its proprietary Viaskin® technology, which offers a unique, non-invasive method for delivering therapeutic proteins through the skin. With a strong presence in Europe and North America, DBV Technologies is recognised for its commitment to advancing patient care through its core product offerings, including the Viaskin Peanut patch, designed to desensitise individuals with peanut allergies. The company has achieved notable milestones, including successful clinical trials and partnerships that enhance its market position in the biopharmaceutical industry. As a leader in allergy treatment innovation, DBV Technologies continues to shape the future of immunotherapy.
How does DBV Technologies S.A.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
DBV Technologies S.A.'s score of 28 is lower than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.
DBV Technologies S.A., headquartered in France, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Furthermore, the company has not established any documented reduction targets or commitments to the Science Based Targets initiative (SBTi) or other climate pledges. As there is no available data on their carbon footprint or reduction initiatives, it is unclear how DBV Technologies S.A. is addressing climate change within its operations. The lack of emissions reporting may suggest an opportunity for the company to enhance its sustainability practices and align with industry standards for climate accountability. In the context of the broader industry, many organisations are increasingly committing to transparent emissions reporting and setting ambitious reduction targets to mitigate climate impact. DBV Technologies S.A. may benefit from adopting similar strategies to demonstrate its commitment to environmental sustainability.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
DBV Technologies S.A. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
